Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Cidara Therapeutics Current Ratio 2014-2019 | CDTX

Cidara Therapeutics current ratio from 2014 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Cidara Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.05B $0.02B 2.57
2019-03-31 $0.06B $0.02B 3.19
2018-12-31 $0.08B $0.02B 3.88
2018-09-30 $0.09B $0.01B 6.78
2018-06-30 $0.11B $0.02B 7.11
2018-03-31 $0.07B $0.01B 5.99
2017-12-31 $0.08B $0.01B 6.43
2017-09-30 $0.07B $0.01B 7.68
2017-06-30 $0.08B $0.01B 7.49
2017-03-31 $0.09B $0.01B 13.26
2016-12-31 $0.11B $0.01B 11.83
2016-09-30 $0.08B $0.01B 9.79
2016-06-30 $0.09B $0.01B 17.22
2016-03-31 $0.10B $0.00B 24.04
2015-12-31 $0.11B $0.01B 18.12
2015-09-30 $0.12B $0.00B 26.99
2015-06-30 $0.12B $0.00B 40.11
2015-03-31 $0.06B $0.00B 15.33
2014-12-31 $0.02B $0.00B 7.16
2014-09-30 $0.00B 0.00
2014-06-30 $0.00B 0.00
2014-03-31 $0.00B 0.00
2013-12-31 $0.00B $0.00B 1.73
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.053B $0.000B
Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives. Its product pipeline includes CD101 IV, a long-acting echinocandin antifungal, CD101 topical and C001 which are in different clinical trial. The company developed its product using Cloudbreak(TM) immunotherapy platform. Cidara Therapeutics, Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.966B 13.32
Gilead Sciences (GILD) United States $83.231B 10.22
CSL (CSLLY) Australia $72.709B 0.00
Celgene (CELG) United States $69.932B 10.82
Vertex Pharmaceuticals (VRTX) United States $44.858B 48.48
Illumina (ILMN) United States $44.542B 52.33
Biogen (BIIB) United States $43.376B 7.71
Regeneron Pharmaceuticals (REGN) United States $31.308B 14.21
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.091B 12.17
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $16.891B 49.71
Exact Sciences (EXAS) United States $13.653B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.549B 0.00
Genmab (GNMSF) Denmark $12.505B 70.14
Seattle Genetics (SGEN) United States $11.778B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.952B 53.35
Alnylam Pharmaceuticals (ALNY) United States $9.507B 0.00
Galapagos (GLPG) Belgium $8.668B 0.00
QIAGEN (QGEN) Netherlands $7.676B 25.22
Bio-Techne Corp (TECH) United States $7.518B 51.94
Guardant Health (GH) United States $6.852B 0.00
Sarepta Therapeutics (SRPT) United States $6.220B 0.00
BeiGene (BGNE) Cayman Islands $6.215B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.092B 0.00
Amarin (AMRN) Ireland $6.048B 0.00
Bluebird Bio (BLUE) United States $5.938B 0.00
Moderna (MRNA) United States $5.871B 0.00
Exelixis (EXEL) United States $5.837B 15.17
Horizon Pharma Public (HZNP) Ireland $4.924B 12.52
ARGENX SE-ADR (ARGX) Netherlands $4.890B 0.00
Ascendis Pharma (ASND) Denmark $4.355B 0.00
Repligen (RGEN) United States $4.228B 82.04
China Biologic Products (CBPO) China $4.060B 25.34
Spark Therapeutics (ONCE) United States $4.007B 0.00
Blueprint Medicines (BPMC) United States $3.904B 0.00
Medicines (MDCO) United States $3.756B 0.00
MorphoSys AG (MOR) Germany $3.690B 0.00
Mirati Therapeutics (MRTX) United States $3.606B 0.00
Alkermes (ALKS) Ireland $3.375B 0.00
Immunomedics (IMMU) United States $3.246B 0.00
Emergent Biosolutions (EBS) United States $2.749B 41.29
Reata Pharmaceuticals (RETA) United States $2.714B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.700B 0.00
Genomic Health (GHDX) United States $2.652B 49.73
Arena Pharmaceuticals (ARNA) United States $2.605B 5.60
MyoKardia (MYOK) United States $2.566B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.512B 0.00
Amicus Therapeutics (FOLD) United States $2.434B 0.00
Halozyme Therapeutics (HALO) United States $2.402B 0.00
Acceleron Pharma (XLRN) United States $2.279B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.264B 0.00
NeoGenomics (NEO) United States $2.255B 120.61
Myriad Genetics (MYGN) United States $2.053B 21.55
Akcea Therapeutics (AKCA) United States $2.041B 0.00
Cambrex (CBM) United States $2.007B 25.37
Zai Lab (ZLAB) China $1.998B 0.00
Ligand Pharmaceuticals (LGND) United States $1.887B 23.86
Denali Therapeutics (DNLI) United States $1.763B 0.00
UniQure (QURE) Netherlands $1.737B 0.00
Insmed (INSM) United States $1.730B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.658B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.565B 0.00
Coherus BioSciences (CHRS) United States $1.435B 0.00
REGENXBIO (RGNX) United States $1.421B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.399B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.335B 0.00
Alector (ALEC) United States $1.324B 0.00
Editas Medicine (EDIT) United States $1.252B 0.00
Sangamo Therapeutics (SGMO) United States $1.246B 0.00
RA PHARMCTL INC (RARX) United States $1.212B 0.00
AnaptysBio (ANAB) United States $1.154B 0.00
Fate Therapeutics (FATE) United States $1.151B 0.00
Innoviva (INVA) United States $1.126B 3.25
Athenex (ATNX) United States $1.093B 0.00
Epizyme (EPZM) United States $1.069B 0.00
Zymeworks (ZYME) Canada $1.014B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.980B 0.00
Twist Bioscience (TWST) United States $0.971B 0.00
Cara Therapeutics (CARA) United States $0.929B 0.00
ANI Pharmaceuticals (ANIP) United States $0.884B 14.77
WAVE Life Sciences (WVE) Singapore $0.879B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.875B 0.00
Codexis (CDXS) United States $0.860B 0.00
Principia Biopharma (PRNB) United States $0.838B 436.88
Arvinas (ARVN) United States $0.820B 0.00
Pharming Group (PHGUF) Netherlands $0.793B 0.00
Zealand Pharma (ZEAL) Denmark $0.766B 8.88
Cytokineticsorporated (CYTK) United States $0.766B 0.00
UROGEN PHARMA (URGN) United States $0.757B 0.00
Anika Therapeutics (ANIK) United States $0.749B 26.50
ZIOPHARM Oncology Inc (ZIOP) United States $0.744B 0.00
Intellia Therapeutics (NTLA) United States $0.727B 0.00
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Vericel (VCEL) United States $0.712B 0.00
Mesoblast (MESO) Australia $0.708B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.703B 25.36
Revance Therapeutics (RVNC) United States $0.617B 0.00
MiMedx (MDXG) United States $0.584B 0.00
DBV Technologies S.A (DBVT) France $0.579B 0.00
Heska (HSKA) United States $0.546B 70.74
Achillion Pharmaceuticals (ACHN) United States $0.532B 0.00
Retrophin (RTRX) United States $0.530B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Cellectis S.A (CLLS) France $0.521B 0.00
Stemline Therapeutics (STML) United States $0.508B 0.00
Intra-Cellular Therapies (ITCI) United States $0.504B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.502B 0.00
Precision BioSciences (DTIL) United States $0.494B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
Syros Pharmaceuticals (SYRS) United States $0.466B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.440B 0.00
Puma Biotechnology (PBYI) United States $0.435B 0.00
BioDelivery Sciences (BDSI) United States $0.429B 0.00
Arcus Biosciences (RCUS) United States $0.424B 0.00
CytomX Therapeutics (CTMX) United States $0.421B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.409B 0.00
Agenus (AGEN) United States $0.408B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.404B 0.00
Adverum Biotechnologies (ADVM) United States $0.399B 0.00
Merus (MRUS) Netherlands $0.398B 0.00
Bellus Health (BLU) Canada $0.391B 0.00
Protagonist Therapeutics (PTGX) United States $0.364B 0.00
AC Immune SA (ACIU) Switzerland $0.351B 26.00
Gritstone Oncology (GRTS) United States $0.350B 0.00
Kadmon Holdings (KDMN) United States $0.344B 0.00
Prothena (PRTA) Ireland $0.342B 0.00
Scholar Rock Holding (SRRK) United States $0.330B 0.00
Theratechnologies (THERF) Canada $0.327B 0.00
Avid Bioservices (CDMO) United States $0.326B 0.00
Albireo Pharma (ALBO) United States $0.316B 0.00
ADMA Biologics Inc (ADMA) United States $0.314B 0.00
Biofrontera AG (BFRA) Germany $0.312B 466.67
Kindred Biosciences (KIN) United States $0.309B 0.00
Sorrento Therapeutics (SRNE) United States $0.309B 0.00
Pfenex (PFNX) United States $0.307B 0.00
Cel-Sci (CVM) United States $0.301B 0.00
Starpharma Holdings (SPHRY) Australia $0.295B 0.00
Dynavax Technologies (DVAX) United States $0.289B 0.00
Cellular Biomedicine (CBMG) United States $0.288B 0.00
Clovis Oncology (CLVS) United States $0.281B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.276B 0.00
Geron (GERN) United States $0.271B 0.00
Seres Therapeutics (MCRB) United States $0.267B 0.00
Senesco Technologies (ELOX) United States $0.259B 0.00
MannKind (MNKD) United States $0.254B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.250B 0.00
ChromaDex (CDXC) United States $0.250B 0.00
Sutro Biopharma (STRO) United States $0.249B 0.00
PDL BioPharma (PDLI) United States $0.249B 6.41
Inovio Pharmaceuticals (INO) United States $0.249B 0.00
Prometic Life Sciences (PFSCF) Canada $0.242B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.240B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.238B 0.00
Affimed (AFMD) Germany $0.228B 0.00
POXEL SA FRANCE (PXXLF) France $0.228B 0.00
Athersys (ATHX) United States $0.224B 0.00
Spero Therapeutics (SPRO) United States $0.224B 0.00
Compugen (CGEN) Israel $0.220B 0.00
EXICURE INC (XCUR) United States $0.217B 0.00
Palatin Technologies (PTN) United States $0.215B 6.32
Bicycle Therapeutics (BCYC) United Kingdom $0.213B 0.00
Kamada (KMDA) Israel $0.207B 7.92
CorMedix Inc (CRMD) United States $0.203B 0.00
Cue Biopharma (CUE) United States $0.199B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.197B 0.00
Five Prime Therapeutics (FPRX) United States $0.196B 0.00
XOMA (XOMA) United States $0.188B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.183B 0.00
Arsanis (XFOR) United States $0.175B 0.00
Nicox SA (NICXF) France $0.173B 0.00
Acorda Therapeutics (ACOR) United States $0.171B 0.00
Enzo Biochem (ENZ) United States $0.168B 0.00
Alcobra (ARCT) United States $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Dyadic (DYAI) United States $0.164B 0.00
Novavax (NVAX) United States $0.161B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.159B 0.00
Abeona Therapeutics (ABEO) United States $0.158B 0.00
Strongbridge Biopharma (SBBP) United States $0.150B 6.16
BioTime (LCTX) United States $0.150B 10.00
Northwest Biotherapeutics (NWBO) United States $0.145B 0.00
Cerecor (CERC) United States $0.143B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.143B 0.00
PHASEBIO PHARMA (PHAS) United States $0.142B 0.00
Adocia (ADOCY) France $0.140B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.135B 0.00
Aptinyx (APTX) United States $0.134B 0.00
NantKwest (NK) United States $0.134B 0.00
Emmaus Life Sciences (EMMA) United States $0.133B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Fortress Biotech (FBIO) United States $0.125B 0.00
Menlo Therapeutics (MNLO) United States $0.122B 0.00
SESEN BIO, INC (SESN) United States $0.111B 0.00
Celyad SA (CYAD) Belgium $0.101B 0.00
Aduro Biotech (ADRO) United States $0.100B 0.00
Verastem (VSTM) United States $0.096B 0.00
OvaScience (MLND) United States $0.094B 0.00
VTv Therapeutics (VTVT) United States $0.093B 0.00
Trevena (TRVN) United States $0.093B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.092B 0.00
Arbutus Biopharma (ABUS) Canada $0.091B 0.00
Vaccinex (VCNX) United States $0.090B 0.00
Checkpoint Therapeutics (CKPT) United States $0.090B 0.00
Mersana Therapeutics (MRSN) United States $0.087B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.086B 0.00
Idera Pharmaceuticals (IDRA) United States $0.084B 0.00
Selecta Biosciences (SELB) United States $0.080B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.078B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.076B 0.00
NewLink Genetics (NLNK) United States $0.073B 0.00
Catalyst Biosciences (CBIO) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
Curis (CRIS) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 38.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Orgenesis (ORGS) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.067B 0.00
Pluristem Therapeutics (PSTI) Israel $0.067B 0.00
VBI Vaccines (VBIV) United States $0.066B 0.00
AquaBounty Technologies (AQB) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.062B 0.00
Unum Therapeutics (UMRX) United States $0.061B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.059B 0.00
Prima BioMed (IMMP) Australia $0.057B 0.00
AIT Therapeutics (XAIR) United States $0.050B 0.00
VistaGen Therapeutics (VTGN) United States $0.050B 0.00
Proteostasis Therapeutics (PTI) United States $0.048B 0.00
Stellar Biotechnologies (EDSA) Canada $0.046B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
Oncobiologics (OTLK) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
VIVUS (VVUS) United States $0.045B 0.00
Evogene (EVGN) Israel $0.042B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
BIOCARDIA INC (BCDA) United States $0.039B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.033B 0.00
Protalix BioTherapeutics (PLX) Israel $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.028B 9.73
Apricus Biosciences (SEEL) United States $0.027B 0.00
Clearside Biomedical (CLSD) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
TOCAGEN INC (TOCA) United States $0.020B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
IBio (IBIO) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00